​​​​​​​​​​​​​ On this page

Serious scarcity medicine substitution

In some circumstances it is legal for a retail pharmacist to substitute different strengths or formulations of a prescribed medicine, without contacting the prescriber.

Where there is a Serious Scarcity Substitution Notice on the TGA, substitution is permitted if it is appropriate and the patient consents. The notice will specify which products may be substituted and the specific circumstances it may be substituted.

Under Part 4A of the NSW Poisons and Therapeutic Goods Act 1966, pharmacists must comply with all provisions of the relevant Commonwealth Serious Scarcity and Substitutable Medicine Instrument.

For information on subsidy under the Commonwealth Pharmaceutical Benefits Scheme, visit the PBS.


Approval for use of an Electronic National Residential Medication Chart (eNRMC)

The Commonwealth PBS transitional arrangements for use of an electronic National Residential Medication Chart (eNRMC) is under the National Health (Electronic National Residential Medication Chart Trial) Special Arrangement 2018.

Under legal instruments issued under the NSW Poisons and Therapeutic Goods Regulation 2008 a prescription may be issued for a person receiving residential care using an eNRMC:

a) At an approved residential care service specified in the Schedule to the Special Arrangement, or
b) Listed on the Transitional eNRMC Conformance Register maintained by the Australian Digital Health Agency.

Medication chart orders on the eNRMC satisfy as a form of prescription for pharmacist dispensing and also direct administration by RCF staff.

This applies to all medicines prescribed for RCF residents (that is, PBS and non-PBS).

[back to top]​

Current as at: Wednesday 9 October 2024
Contact page owner: Pharmaceutical Services